Literature DB >> 20663326

Wyburn-Mason or Bonnet-Dechaume-Blanc as Cerebrofacial Arteriovenous Metameric Syndromes (CAMS). A New Concept and a New Classification.

J J Bhattacharya1, C B Luo, D C Suh, H Alvarez, G Rodesch, P Lasjaunias.   

Abstract

SUMMARY: The diagnosis of Bonnet-Dechaume-Blanc or Wyburn-Mason syndrome encompasses a spectrum of phenotypic expression. Features of the syndrome as originally described, and common to all, include arteriovenous malformations of the brain and orbit (with retinal and/or retrobulbar lesions). A portion of these patients manifest the complete expression of the disease with additional high-flow arteriovenous malformations of the maxillofacial or mandibular regions. These present the distinct and additional risks of lifethreatening epistaxis or gingival haemorrhage. We suggest new diagnostic criteria for the syndrome. Applying insights from modern developmental biology to our series of 15 patients (the largest to date), together with a review of the literature, we have recognised metameric patterns of involvement in what we believe to be a disease of the neural crest or adjacent cephalic mesoderm. This allows us to propose a new rational classification reflecting the putative, underlying disorder and to suggest a new name: Cerebrofacial Arteriovenous Metameric Syndrome (CAMS).

Entities:  

Year:  2001        PMID: 20663326      PMCID: PMC3621461          DOI: 10.1177/159101990100700101

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  19 in total

1.  [Iconography of neuroretinal angiomatosis; Bonnet-Dechaune-Blanc syndrome].

Authors:  H FISCHGOLD; P BREGEAT; Y LE BESNERAIS; M DAVID
Journal:  Presse Med       Date:  1952-12-25       Impact factor: 1.228

2.  Segmental patterns of neuronal development in the chick hindbrain.

Authors:  A Lumsden; R Keynes
Journal:  Nature       Date:  1989-02-02       Impact factor: 49.962

Review 3.  Expression patterns of homeobox and other putative regulatory genes in the embryonic mouse forebrain suggest a neuromeric organization.

Authors:  L Puelles; J L Rubenstein
Journal:  Trends Neurosci       Date:  1993-11       Impact factor: 13.837

Review 4.  Wyburn-Mason syndrome. A case report and review of the literature.

Authors:  U Patel; S C Gupta
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

5.  Neural crest cell contribution to the developing circulatory system: implications for vascular morphology?

Authors:  M Bergwerff; M E Verberne; M C DeRuiter; R E Poelmann; A C Gittenberger-de Groot
Journal:  Circ Res       Date:  1998-02-09       Impact factor: 17.367

Review 6.  Mechanisms of angiogenesis.

Authors:  W Risau
Journal:  Nature       Date:  1997-04-17       Impact factor: 49.962

7.  Unilateral retinocephalic vascular malformations.

Authors:  J Théron; T H Newton; W F Hoyt
Journal:  Neuroradiology       Date:  1974       Impact factor: 2.804

8.  Wyburn-Mason syndrome. Report of two cases without retinal involvement.

Authors:  D G Brown; S K Hilal; M S Tenner
Journal:  Arch Neurol       Date:  1973-01

9.  The nidus concept of spinal cord arteriovenous malformations. A surgical recommendation based upon angiographic observations.

Authors:  J L Doppman
Journal:  Br J Radiol       Date:  1971-10       Impact factor: 3.039

10.  Multiple arteriovenous malformations involving the scalp, dura, retina, cerebrum, and posterior fossa. Case report.

Authors:  N Tamaki; K Fujita; H Yamashita
Journal:  J Neurosurg       Date:  1971-01       Impact factor: 5.115

View more
  33 in total

1.  Endovascular Treatment of AVMs in Glasgow.

Authors:  J J Bhattacharya; S Jenkins; P Zampakis; M Behbahani; E Teasdale; V Papanastassiou
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

2.  Role of the cerebral ultrasound in a case of Sturge-Weber syndrome.

Authors:  Ana Ferraz; Sofia Morais; Gabriela Mimoso
Journal:  BMJ Case Rep       Date:  2019-04-08

3.  Wyburn-Mason syndrome associated with thyroid arteriovenous malformation: a first case report.

Authors:  A W Lee; C S Chen; P Gailloud; P Nyquist
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

4.  Enlargement of the Internal Auditory Canal and Associated Posterior Fossa Anomalies in PHACES Association.

Authors:  D E Meltzer; C D Robson; F Blei; R A Holliday
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-09       Impact factor: 3.825

5.  Spinal arteriovenous metameric syndrome: angioarchitecture and their prognosis.

Authors:  I S Choi
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-30       Impact factor: 3.825

Review 6.  Multifocal arteriovenous malformations and facial nevus without leptomeningeal angioma: a variant form of Sturge-Weber syndrome? A case report and review of the literatures.

Authors:  In-Seok Bae; Hyeong-Joong Yi; Young Jun Lee
Journal:  Childs Nerv Syst       Date:  2012-09-30       Impact factor: 1.475

7.  Growing dural sinus malformation with associated developmental venous anomaly, multiple cavernomas and facial venous malformation in an infant. An associated disease or a disease spectrum?

Authors:  Z Mohamed; L L Batista; M Sachet; J Mahadevan; H Alvarez; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

8.  Multifocal cerebral venous malformations and associated developmental venous anomalies in a case of blue rubber bleb nevus syndrome.

Authors:  J I Chung; H Alvarez; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

9.  Endovascular treatment of head and neck arteriovenous malformations.

Authors:  A A Dmytriw; K G Ter Brugge; T Krings; R Agid
Journal:  Neuroradiology       Date:  2014-01-28       Impact factor: 2.804

Review 10.  [Retinal tumors in adults - Part 1: vascular tumors of the retina].

Authors:  Roya Piria; Felix Rommel; Michael Zimbelmann; Kristina Erikson; Neele Babst; Anton Brosig; Josephine Christin Freitag; Mahdy Ranjbar; Salvatore Grisanti; Vinodh Kakkassery
Journal:  Ophthalmologe       Date:  2021-07-26       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.